Weight loss drugs tied to deaths and pancreatitis in UK while regulators delay action and launch gene study

Nearly 300 pancreatitis reports and 6 deaths.

The medicines regulator is investigating after hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs.

The Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England have launched the Yellow Card Biobank project to examine whether cases of pancreatitis linked to GLP-1 drugs may be influenced by people’s genetic makeup.

New MHRA data shows that since the drugs were licensed, there have been hundreds of cases of acute and chronic pancreatitis among people taking GLP-1 medicines.

https://www.the-independent.com/life-style/health-and-families/mounjaro-pancreatitis-symptoms-weight-loss-injections-b2777328.html